Lifeward (NASDAQ:LFWD – Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Friday, March 6th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $7.8680 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, March 13, 2026 at 10:30 AM ET.
Lifeward Stock Down 5.6%
Shares of LFWD stock opened at $6.40 on Wednesday. Lifeward has a 52-week low of $4.14 and a 52-week high of $35.40. The stock has a market cap of $9.73 million, a PE ratio of -0.18 and a beta of 0.12. The business has a 50-day simple moving average of $7.12 and a 200-day simple moving average of $7.48.
Wall Street Analysts Forecast Growth
LFWD has been the subject of a number of analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. HC Wainwright dropped their price target on shares of Lifeward from $156.00 to $54.00 and set a “buy” rating on the stock in a research report on Tuesday, November 18th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $51.00.
Hedge Funds Weigh In On Lifeward
A number of large investors have recently added to or reduced their stakes in LFWD. Citadel Advisors LLC grew its position in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the period. HRT Financial LP lifted its stake in Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after buying an additional 29,423 shares in the last quarter. Jane Street Group LLC boosted its holdings in Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares during the last quarter. Finally, Virtu Financial LLC boosted its holdings in Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after buying an additional 37,037 shares during the last quarter. 26.76% of the stock is currently owned by institutional investors and hedge funds.
About Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
See Also
- Five stocks we like better than Lifeward
- New Copper-Rich “Kraken” Zone Discovered
- 3 Signs You May Want to Switch Financial Advisors
- Trade this between 9:30 and 10:45 am EST
- Silver’s squeeze is tightening – opportunity forming
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
